fuga mobilya
fuga mobilya
fuga mobilya
fuga mobilya
fuga mobilya
fuga mobilya
fuga mobilya
fuga mobilya
fuga mobilya
fuga mobilya
fuga mobilya
fuga mobilya
fuga mobilya
Mission
   

In The News

SFJ Pharma LTD. II, Announces Agreement with Pfizer to develop Axitinib for adjuvant treatment of renal cell carcinoma.

View the Press Release

U.S. FDA Grants Priority Review Status to NDA for anticancer agent Lenvatinib

View the Press Release


The SFJ Pharmaceuticals Group announces agreement with Pfizer to co-develop Dacomitnib as first-line treatment for patients with advances non-small cell cancer.

View the Press Release


Mission
The SFJ Pharmaceuticals Group mission is to accelerate the availability of new and innovative drugs into the world's major markets, by providing not only additional funding, but also strategic development expertise to enable our Pharma and Biotech partners to be as hands off or as hands on as they wish.

Currently there is significant downward pressure on drug development resources. In the case of large Pharma the so called "patent cliff" has hit hard leaving no company unaffected. This leads to dramatic R+D budget cuts. For Biotech there is a chronic lack of external funding available.

The SFJ Pharmaceuticals Group mission is to enable these companies to continue to develop their most important drug candidates without increasing the burden on their P&L or cash reserves. SFJ will take 100% of the clinical and regulatory risk.

 

Mission

The SFJ Pharmaceuticals Group mission is to accelerate the availability of new and innovative drugs into the world's major markets, by providing not only additional funding, but also strategic development expertise to enable our Pharma and Biotech partners to be as hands off or as hands on as they wish.

Target Market

SFJ Pharmaceuticals Group is primarily focused on funding and / or executing global or regional Phase III studies.

SFJ Pharmaceuticals Group is positioned to develop prescription drugs in any and all therapeutic areas, where there is a clear medical and market need.